Industry News

Aug 20, 2014

Blood test may revolutionize brain cancer diagnosis

Scientists at Virginia Tech's Virginia Bioinformatics Institute working with the Center for Cancer and Blood Disorders at Children's National Medical Center have found a new way to diagnose brain... Read More
Aug 20, 2014

Blueprint for the next generation of chronic myeloid leukemia treatment

Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have identified and characterized mutated forms of the gene that encodes BCR-ABL, the unregulated enzyme driving the blood... Read More
Aug 20, 2014

NICE clears path for patient access to Revlimid® (lenalidomide) for rare form of blood cancer

Celgene is pleased to announce that the National Institute for Health and Care Excellence (NICE) has issued a final appraisal determination (FAD) on its oral blood cancer treatment REVLIMID®... Read More
Aug 20, 2014

Novel oral anticoagulant prescriptions soar, but at a high cost

Warfarin, the longtime standard treatment for atrial fibrillation, is facing competition from new options in the anticoagulant drug marketplace including dabigatran, rivaroxaban, and apixaban. Read More
Aug 20, 2014

Web-based app developed to predict glioma mutations

A new web-based program developed by University of Kentucky Markey Cancer Center researchers will provide a simple, free way for healthcare providers to determine which brain tumor cases require... Read More
Aug 20, 2014

Multiplying immune-system cells to battle pediatric leukemia

Researchers at Children's Hospital Los Angeles have shown that a select team of immune-system cells from patients with leukemia can be multiplied in the lab, creating an army of natural killer cells... Read More
Aug 20, 2014

Gastric cancer: could Botox be an alternative to chemo?

Research into the role of the vagal nerve in stomach cancer has led to novel methods for severing the nerve-tumor connection. One of these, surprisingly, is Botox injections. Read More
Aug 20, 2014

Transient axonal glycoprotein-1 induces apoptosis-related gene expression without triggering glioma apoptosis

A recent study reported by Haigang Chang and co-workers from the First Affiliated Hospital of Xinxiang Medical University in China verified the effects of transient axonal glycoprotein-1 (TAG-1) on... Read More
Aug 20, 2014

Dasatinib, a leukemia drug, has the potential to treat many cancers

A leukemia drug called dasatinib shows promise for treating skin, breast and several other cancers, according to researchers at Loyola University Chicago Stritch School of Medicine. Read More
Aug 20, 2014

Patient, tumor characteristics for high-mitotic rate melanoma

A study in Australia examined patient and tumor characteristics for melanomas with higher mitotic rates (a marker of tumor cell growth) in an effort to increase earlier detection of this aggressive... Read More
Next Page